Last Close
Apr 09  •  11:42AM ET
87.71
Dollar change
-0.94
Percentage change
-1.06
%
Index
S&P 500
P/E
24.49
EPS (ttm)
3.58
Insider Own
-
Shs Outstand
1.28B
Perf Week
1.92%
Market Cap
112.61B
Forward P/E
14.43
EPS next Y
6.08
Insider Trans
-
Shs Float
1.28B
Perf Month
-2.43%
Enterprise Value
132.51B
PEG
2.45
EPS next Q
1.55
Inst Own
87.19%
Perf Quarter
-12.09%
Income
4.61B
P/S
3.17
EPS this Y
3.23%
Inst Trans
0.18%
Perf Half Y
-10.80%
Sales
35.48B
P/B
2.30
EPS next Y
7.25%
ROA
5.09%
Perf YTD
-8.69%
Book/sh
38.17
P/C
13.43
EPS next 5Y
5.89%
ROE
9.38%
52W High
106.33 -17.51%
Perf Year
2.85%
Cash/sh
6.53
P/FCF
20.82
EPS past 3/5Y
-1.03% 0.39%
ROIC
6.00%
52W Low
79.55 10.26%
Perf 3Y
9.23%
EV/EBITDA
13.88
Sales past 3/5Y
1.91% 3.01%
Gross Margin
59.59%
Volatility
1.90% 1.95%
Perf 5Y
-28.11%
EV/Sales
3.73
EPS Y/Y TTM
9.06%
Oper. Margin
18.23%
ATR (14)
1.79
Perf 10Y
14.85%
Quick Ratio
1.87
Sales Y/Y TTM
6.88%
Profit Margin
13.00%
RSI (14)
43.97
Current Ratio
2.54
EPS Q/Q
-11.90%
SMA20
0.70%
Beta
0.74
Debt/Eq
0.57
Sales Q/Q
8.74%
SMA50
-6.40%
Rel Volume
0.85
Prev Close
88.65
Employees
95000
LT Debt/Eq
0.57
SMA200
-7.17%
Avg Volume
8.59M
Price
87.71
IPO
Nov 21, 1977
Option/Short
Yes / Yes
Trades
Volume
2,708,083
Change
-1.06%
Date Action Analyst Rating Change Price Target Change
Feb-13-26Resumed Barclays Overweight $116
Feb-09-26Upgrade Needham Hold → Buy $121
Feb-03-26Resumed Citigroup Buy $117
Jan-30-26Resumed Wells Fargo Overweight $114
Jan-06-26Upgrade William Blair Mkt Perform → Outperform
Nov-19-25Upgrade Goldman Sell → Neutral $111
Jun-30-25Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25Initiated Leerink Partners Outperform $110
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Apr-08-26 09:31AM
Apr-07-26 06:50AM
Apr-06-26 06:00AM
Apr-01-26 11:47PM
09:46AM
03:09PM Loading…
Mar-31-26 03:09PM
06:30AM
Mar-30-26 07:04AM
01:40AM
Mar-27-26 09:00AM
Mar-25-26 08:31AM
07:43AM
Mar-24-26 06:47AM
Mar-23-26 01:40PM
09:00AM
11:14AM Loading…
Mar-18-26 11:14AM
07:13AM
Mar-16-26 04:57PM
11:17AM
Mar-11-26 06:31AM
Mar-10-26 02:19PM
12:05PM
11:40AM
11:39AM
11:21AM
08:37AM
06:58AM
06:45AM
Mar-09-26 12:17PM
08:45AM
02:53PM Loading…
Mar-06-26 02:53PM
10:30AM
09:00AM
Mar-05-26 07:33PM
04:53PM
05:03AM
Mar-04-26 12:38AM
Mar-03-26 11:30AM
10:31AM
10:15AM
09:10AM
Feb-26-26 11:21AM
08:14AM
Feb-25-26 08:30AM
07:31AM
Feb-24-26 12:02PM
11:33AM
10:42AM
10:27AM
08:30AM
08:00AM
06:25AM
Feb-23-26 03:33PM
01:13PM
12:25PM
12:25PM
05:56AM
Feb-21-26 07:00AM
Feb-20-26 05:46AM
05:41AM
Feb-19-26 11:01AM
Feb-18-26 09:50AM
08:18AM
07:51AM
Feb-17-26 06:18PM
05:01PM
04:33PM
04:25PM
04:21PM
02:09PM
02:00PM
01:46PM
12:32PM
11:22AM
11:11AM
10:48AM
10:35AM
10:20AM
09:42AM
09:41AM
09:40AM
09:34AM
09:34AM
09:30AM
09:21AM
07:55AM
07:40AM
07:27AM
07:05AM
06:53AM
06:45AM
06:44AM
03:45AM
03:45AM
Feb-16-26 09:55AM
09:42AM
07:00AM
Feb-15-26 01:00PM
07:57AM
Feb-13-26 07:00PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIIL HARRY SKIPEVP & President CardiovascularFeb 19 '26Option Exercise90.9050,8764,624,51285,292Feb 26 05:48 PM
KIIL HARRY SKIPEVP & President CardiovascularFeb 19 '26Sale97.7152,5245,132,21732,768Feb 26 05:48 PM
KIIL HARRY SKIPOfficerFeb 19 '26Proposed Sale97.7152,5245,132,217Feb 19 03:19 PM
Smith Gregory LEVP Global Ops & Supply ChainNov 19 '25Sale101.9530,0003,058,45146,016Nov 21 04:13 PM
Smith Gregory LOfficerNov 19 '25Proposed Sale101.9530,0003,058,452Nov 19 11:05 AM
KIIL HARRY SKIPEVP & President CardiovascularSep 03 '25Sale91.588,605788,04835,615Sep 05 04:18 PM
KIIL HARRY SKIPOfficerSep 03 '25Proposed Sale91.588,605788,049Sep 03 03:23 PM
Jellison William RDirectorAug 22 '25Buy92.732,500231,8252,500Aug 25 05:18 PM
Jellison William RDirectorAug 25 '25Buy92.372,500230,9255,000Aug 25 05:18 PM
Walter Matthew R.SVP, Chief HR OfficerAug 01 '25Option Exercise23.913,14275,11432,804Aug 04 04:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 01 '25Option Exercise0.0015,249066,531Aug 04 04:20 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 01 '25Option Exercise0.0011,328083,071Aug 04 04:19 PM
Martha GeoffreyChairman and CEOAug 01 '25Option Exercise32.2198,3243,166,800284,923Aug 04 04:18 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasAug 01 '25Option Exercise25.249,661243,82857,628Aug 04 04:17 PM
KIIL HARRY SKIPEVP & President CardiovascularAug 01 '25Option Exercise0.0010,457051,775Aug 04 04:16 PM
Blomquist Denise L.Chief Accounting OfficerAug 01 '25Option Exercise32.2251816,69212,671Aug 04 04:15 PM
Salmon SeanOfficerJun 06 '25Proposed Sale86.8118,3781,595,469Jun 06 02:43 PM